HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 3 June 2014

Pharmacoeconomic Guidelines update

ISPOR’s Pharmacoeconomic Guidelines resource has now added Slovenian Guidelines.  In addition, Pharmacoeconomic Guidelines for New Zealand have been updated to show discounting at 8% and the requirements for a financial impact statement.  Other recent revisions have been made to the guidelines for Finland, Hungary, Belgium, Germany, The Netherlands, Portugal, United States, and the Slovak Republic.